This is a contrast between Boston Scientific Corporation (NYSE:BSX) and Micron Solutions Inc. (NYSEAMERICAN:MICR) based on their profitability, analyst recommendations, risk, dividends, institutional ownership, earnings and valuation. The two companies are Medical Appliances & Equipment and they also compete with each other.

Earnings & Valuation

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Boston Scientific Corporation	9.82B	5.40	1.67B	1.15	35.20
Micron Solutions Inc.	19.56M	0.43	1.10M	-0.08	0.00

Table 1 shows top-line revenue, earnings per share and valuation of the two companies.

Profitability

Table 2 has Boston Scientific Corporation and Micron Solutions Inc.’s return on assets, return on equity and net margins.

	Net Margins	Return on Equity	Return on Assets
Boston Scientific Corporation	17.01%	21%	8.3%
Micron Solutions Inc.	-5.62%	-11.8%	-4.4%

Volatility and Risk

Boston Scientific Corporation’s volatility measures that it’s 11.00% less volatile than S&P 500 due to its 0.89 beta. Competitively, Micron Solutions Inc.’s beta is 0.4 which is 60.00% less volatile than S&P 500.

Liquidity

The Current Ratio of Boston Scientific Corporation is 0.8 while its Quick Ratio stands at 0.5. The Current Ratio of rival Micron Solutions Inc. is 1.6 and its Quick Ratio is has 0.7. Micron Solutions Inc. is better equipped to clear short and long-term obligations than Boston Scientific Corporation.

Analyst Ratings

The table given features the ratings and recommendations for Boston Scientific Corporation and Micron Solutions Inc.

	Sell Ratings	Hold Ratings	Buy Ratings	Rating Score
Boston Scientific Corporation	0	0	6	3.00
Micron Solutions Inc.	0	0	0	0.00

The average price target of Boston Scientific Corporation is $43, with potential upside of 12.68%.

Insider and Institutional Ownership

Institutional investors held 93.9% of Boston Scientific Corporation shares and 12.7% of Micron Solutions Inc. shares. About 0.3% of Boston Scientific Corporation’s share are held by insiders. Insiders Comparatively, held 12.1% of Micron Solutions Inc. shares.

Performance

In this table we show the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.

	Performance (W)	Performance (M)	Performance (Q)	Performance (HY)	Performance (Y)	Performance (YTD)
Boston Scientific Corporation	0.78%	5.64%	9.96%	13.39%	52.08%	14.04%
Micron Solutions Inc.	6%	14%	-9.24%	-14.16%	-18.57%	7.14%

For the past year Boston Scientific Corporation was more bullish than Micron Solutions Inc.

Summary

On 11 of the 12 factors Boston Scientific Corporation beats Micron Solutions Inc.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: Cardiovascular, Rhythm Management, and MedSurg. The company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; other coronary therapy products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as certain peripheral vessels; and structural heart therapy systems. It also provides stents, balloon catheters, wires, peripheral embolization devices, and vena cava filters used to treat peripheral arterial disease; and biliary stents, drainage catheters, and micro-puncture sets to treat, diagnose, and ease benign and malignant tumors. In addition, the company offers cardiac rhythm management devices, such as implantable cardioverter defibrillator systems to detect and treat abnormally fast heart rhythms; implantable cardiac resynchronization therapy pacemaker systems used to treat heart failure; and medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising steerable radio frequency ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories. Further, it provides products to diagnose and treat diseases of the pulmonary and gastrointestinal conditions; devices to diagnose, treat, and ease pulmonary disease systems within the airway and lungs; products to treat urinary stone disease and benign prostatic hyperplasia; mid-urethral sling products, sling and graft materials, pelvic floor reconstruction kits, and suturing devices; and spinal cord stimulator systems for the management of chronic pain. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.